Large area local anesthesia (LALA) in submuscular breast augmentation.
[BACKGROUND] Large area local anesthesia (LALA) has been recommended for decreasing localized pain and shortening discharge time after breast augmentation surgery.
APA
Parker WL, Charbonneau R (2004). Large area local anesthesia (LALA) in submuscular breast augmentation.. Aesthetic surgery journal, 24(5), 436-41. https://doi.org/10.1016/j.asj.2004.06.003
MLA
Parker WL, et al.. "Large area local anesthesia (LALA) in submuscular breast augmentation.." Aesthetic surgery journal, vol. 24, no. 5, 2004, pp. 436-41.
PMID
19336190
Abstract
[BACKGROUND] Large area local anesthesia (LALA) has been recommended for decreasing localized pain and shortening discharge time after breast augmentation surgery. However, quantifiable, objective outcome data for evaluation of the effectiveness of LALA in aesthetic plastic surgery procedures have not yet been reported.
[OBJECTIVE] We conducted a retrospective patient chart review to determine whether irrigation of the submuscular pocket with bupivacaine in retropectoral breast augmentation procedures quantifiably alters the patient's postoperative course with respect to narcotic requirement, nausea and vomiting, and time to discharge. The findings were evaluated in the context of a critical review of the literature dealing with pain management after breast augmentation, and in particular with the use of LALA.
[METHODS] All procedures were performed by the senior author in a private surgical facility. All patients received an identical general anesthetic plus local infiltration of incisions with 1% lidocaine with epinephrine. An inframammary approach was used in all cases; retropectoral dissection was performed with electrocautery dissection followed by hemostasis. In one cohort of patients the submuscular pocket was irrigated with 10 mL of 0.125% bupivacaine before dissection of the contralateral side; in a second control cohort it was not. Postoperative care was the same for both groups.
[RESULTS] We found a trend toward decreased nausea and vomiting and narcotic use, and a statistically significant decrease in time to discharge, for the cohort that received intraoperative bupivacaine irrigation.
[CONCLUSIONS] LALA is an effective means to decrease recovery time and possibly postoperative pain, nausea and vomiting, and narcotic requirements. Because evidence-based medicine is the surest basis for clinical decisions, evaluation of LALA as well as other treatment modalities should include quantifiable outcome measures.
[OBJECTIVE] We conducted a retrospective patient chart review to determine whether irrigation of the submuscular pocket with bupivacaine in retropectoral breast augmentation procedures quantifiably alters the patient's postoperative course with respect to narcotic requirement, nausea and vomiting, and time to discharge. The findings were evaluated in the context of a critical review of the literature dealing with pain management after breast augmentation, and in particular with the use of LALA.
[METHODS] All procedures were performed by the senior author in a private surgical facility. All patients received an identical general anesthetic plus local infiltration of incisions with 1% lidocaine with epinephrine. An inframammary approach was used in all cases; retropectoral dissection was performed with electrocautery dissection followed by hemostasis. In one cohort of patients the submuscular pocket was irrigated with 10 mL of 0.125% bupivacaine before dissection of the contralateral side; in a second control cohort it was not. Postoperative care was the same for both groups.
[RESULTS] We found a trend toward decreased nausea and vomiting and narcotic use, and a statistically significant decrease in time to discharge, for the cohort that received intraoperative bupivacaine irrigation.
[CONCLUSIONS] LALA is an effective means to decrease recovery time and possibly postoperative pain, nausea and vomiting, and narcotic requirements. Because evidence-based medicine is the surest basis for clinical decisions, evaluation of LALA as well as other treatment modalities should include quantifiable outcome measures.
추출된 의학 개체 (NER)
| 유형 | 영어 표현 | 한국어 / 풀이 | UMLS CUI | 출처 | 등장 |
|---|---|---|---|---|---|
| 시술 | breast augmentation
|
유방성형술 | dict | 4 | |
| 해부 | breast
|
유방 | dict | 4 | |
| 기법 | submuscular
|
근막하 평면 | dict | 3 | |
| 합병증 | submuscular breast
|
scispacy | 1 | ||
| 합병증 | retropectoral breast
|
scispacy | 1 | ||
| 합병증 | inframammary
|
scispacy | 1 | ||
| 약물 | LALA
→ local anesthesia
|
C0002921
Local anesthesia
|
scispacy | 1 | |
| 약물 | bupivacaine
|
C0006400
bupivacaine
|
scispacy | 1 | |
| 약물 | [BACKGROUND] Large area
|
scispacy | 1 | ||
| 약물 | [CONCLUSIONS] LALA
|
scispacy | 1 | ||
| 약물 | lidocaine
|
리도카인 | dict | 1 | |
| 약물 | epinephrine
|
에피네프린 | dict | 1 | |
| 질환 | pain
|
C0030193
Pain
|
scispacy | 1 | |
| 질환 | nausea and
|
scispacy | 1 | ||
| 질환 | vomiting
|
C0042963
Vomiting
|
scispacy | 1 | |
| 질환 | nausea and vomiting
|
C0027498
Nausea and vomiting
|
scispacy | 1 | |
| 질환 | postoperative pain
|
C0030201
Pain, Postoperative
|
scispacy | 1 | |
| 질환 | nausea
|
C0027497
Nausea
|
scispacy | 1 | |
| 기타 | retropectoral
|
scispacy | 1 | ||
| 기타 | LALA
→ local anesthesia
|
scispacy | 1 |
🔗 함께 등장하는 도메인
이 논문이 속한 카테고리와 같은 논문에서 자주 함께 다뤄지는 카테고리들
같은 제1저자의 인용 많은 논문 (1)
관련 논문
- The impact of three-dimensional simulation and virtual reality technologies on surgical decision-making and postoperative satisfaction in aesthetic surgery: a preliminary study.
- Local therapeutic strategies for neurocutaneous dysesthesia: from capsaicin to cannabinoids.
- Comparative effects of pharmacological interventions in the prophylactic treatment of tension-type headache: systematic review and network meta-analysis.
- Cutaneous fistula of the breast: A complication of cosmetic autologous fat transfer.
- Epidermal inclusion cyst after breast reduction mammoplasty.